Literature DB >> 15255978

Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons.

Laurie A Karchewski1, Stefan Bloechlinger, Clifford J Woolf.   

Abstract

The peripheral benzodiazepine receptor (PBR), a benzodiazepine but not gamma-aminobutyric acid-binding mitochondrial membrane protein, has roles in steroid production, energy metabolism, cell survival and growth. PBR expression in the nervous system has been reported in non-neuronal glial and immune cells. We now show expression of both PBR mRNA and protein, and the appearance of binding of a synthetic ligand, [(3)H]PK11195, in dorsal root ganglion (DRG) neurons following injury to the sciatic nerve. In naïve animals, PBR mRNA, protein expression and ligand binding are undetectable in the DRG. Three days after sciatic nerve transection, however, PBR mRNA begins to be expressed in injured neurons, and 4 weeks after the injury, expression and ligand binding are present in 35% of L4 DRG neurons. PBR ligand binding also appears after injury in the superficial dorsal horn of the spinal cord. The PBR expression in the DRG is restricted to small and medium-sized neurons and returns to naïve levels if the injured peripheral axons are allowed to regrow and reinnervate targets. No non-neuronal PBR expression is detected, unlike its putative endogenous ligand the diazepam binding inhibitor (DBI), which is expressed only in non-neuronal cells, including the satellite cells that surround DRG neurons. DBI expression does not change with sciatic nerve transection. PBR acting on small-calibre neurons could play a role in the adaptive survival and growth responses of these cells to injury of their axons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255978     DOI: 10.1111/j.1460-9568.2004.03530.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

Review 1.  Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.

Authors:  Emanuela Leonelli; Marinella Ballabio; Antonio Consoli; Ilaria Roglio; Valerio Magnaghi; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.

Authors:  Jean Luc do Rego; David Vaudry; Hubert Vaudry
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 3.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Peptide signaling during terminal differentiation of Dictyostelium.

Authors:  Christophe Anjard; William F Loomis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

5.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

6.  Etifoxine improves peripheral nerve regeneration and functional recovery.

Authors:  Christelle Girard; Song Liu; Françoise Cadepond; David Adams; Catherine Lacroix; Marc Verleye; Jean-Marie Gillardin; Etienne-Emile Baulieu; Michael Schumacher; Ghislaine Schweizer-Groyer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

7.  Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis.

Authors:  Hayley Hernstadt; Shuxing Wang; Grewo Lim; Jianren Mao
Journal:  Brain Res       Date:  2009-06-23       Impact factor: 3.252

8.  Injury-Dependent and Disability-Specific Lumbar Spinal Gene Regulation following Sciatic Nerve Injury in the Rat.

Authors:  Paul J Austin; Alison L Bembrick; Gareth S Denyer; Kevin A Keay
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

Review 9.  Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone.

Authors:  Pierrick Poisbeau; Anne Florence Keller; Maya Aouad; Nisrine Kamoun; Ghislaine Groyer; Michael Schumacher
Journal:  Front Cell Neurosci       Date:  2014-06-17       Impact factor: 5.505

10.  Completing the Pain Circuit: Recent Advances in Imaging Pain and Inflammation beyond the Central Nervous System.

Authors:  Clas Linnman; David Borsook
Journal:  Rambam Maimonides Med J       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.